Wilke, Carlo
Bender, Friedemann
Hayer, Stefanie N.
Brockmann, Kathrin
Schöls, Ludger
Kuhle, Jens
Synofzik, Matthis
Article History
Received: 29 March 2018
Revised: 28 April 2018
Accepted: 2 May 2018
First Online: 8 May 2018
Compliance with ethical standards
:
: JK’s institution (University Hospital Basel) received in the last 3 years and used exclusively for research support: consulting fees from Novartis, Protagen AG; speaker fees from the Swiss MS Society, Biogen, Novartis, Roche, Genzyme; travel expenses from Merck Serono, Novartis; grants from ECTRIMS Research Fellowship Programme, University of Basel, Swiss MS Society, Swiss National Research Foundation, Bayer (Switzerland) AG, Genzyme, Novartis. MS received speaker’s honoraria and research support from Actelion Pharmaceuticals, unrelated to the current project and manuscript. The other authors declare no competing financial interests.
: The university’s ethics committee approved the study; the methods were carried out in accordance with the relevant guidelines and regulations.
: All the subjects gave a written informed consent prior to participation.
: The datasets analysed in the current study are available from the corresponding author on reasonable request.